GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Education » Afya Ltd (NAS:AFYA) » Definitions » COGS-to-Revenue

Afya (AFYA) COGS-to-Revenue : 0.40 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Afya COGS-to-Revenue?

Afya's Cost of Goods Sold for the three months ended in Dec. 2023 was $59.1 Mil. Its Revenue for the three months ended in Dec. 2023 was $149.0 Mil.

Afya's COGS to Revenue for the three months ended in Dec. 2023 was 0.40.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Afya's Gross Margin % for the three months ended in Dec. 2023 was 60.31%.


Afya COGS-to-Revenue Historical Data

The historical data trend for Afya's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Afya COGS-to-Revenue Chart

Afya Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial 0.41 0.36 0.38 0.37 0.39

Afya Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.41 0.35 0.40 0.40 0.40

Afya COGS-to-Revenue Calculation

Afya's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=226.502 / 586.945
=0.39

Afya's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=59.12 / 148.958
=0.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Afya  (NAS:AFYA) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Afya's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 59.12 / 148.958
=60.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Afya COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Afya's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Afya (AFYA) Business Description

Traded in Other Exchanges
Address
Alameda Oscar Niemeyer, No. 119, Room 504, Vila da Serra, Nova Lima, MG, BRA
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medicine, other health sciences, and other undergraduate programs, Continuing Education provides specialization programs and graduate courses in medicine; and Digital Services provides content and technology for medical education, clinical decisions software, practice management tools (that encompass electronic medical records, telemedicine, and digital prescription, and provides access, demand and efficiency for the healthcare players.